Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste
Obstetrics & Gynecology, 131(5), e140e150
This can be seen in the specifics of the dosing regimen for RYBELSUS semaglutide tablets, which must be taken after waking, on an empty stomach, and with no more than four ounces (~120ml) of plain water
This guide covers the five-tier timeline reference, payer-by-payer breakdowns, the 2026 CMS regulatory context, how long prior authorization takes to work through once submitted, eight provider actions to speed up approvals, and the denial recovery workflow